List of Tables

Table 1. Lenvatinib Mesilate Capsules Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Lenvatinib Mesilate Capsules Market Restraints

Table 3. Lenvatinib Mesilate Capsules Market Trends

Table 4. Lenvatinib Mesilate Capsules Industry Policy

Table 5. Global Lenvatinib Mesilate Capsules Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Lenvatinib Mesilate Capsules Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Lenvatinib Mesilate Capsules Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Lenvatinib Mesilate Capsules Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Lenvatinib Mesilate Capsules Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Lenvatinib Mesilate Capsules Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Lenvatinib Mesilate Capsules Mergers & Acquisitions, Expansion Plans

Table 12. Global Lenvatinib Mesilate Capsules Manufacturers Product Type

Table 13. Head Office and Lenvatinib Mesilate Capsules Production Site of Key Manufacturer

Table 14. Lenvatinib Mesilate Capsules Capacity of Major Manufacturers and Future Plan

Table 15. China Lenvatinib Mesilate Capsules Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Lenvatinib Mesilate Capsules Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Lenvatinib Mesilate Capsules Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Lenvatinib Mesilate Capsules Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Lenvatinib Mesilate Capsules Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Lenvatinib Mesilate Capsules Production by Region, 2020-2025, (K Units)

Table 21. Global Lenvatinib Mesilate Capsules Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Lenvatinib Mesilate Capsules Upstream (Raw Materials)

Table 23. Global Lenvatinib Mesilate Capsules Typical Customers

Table 24. Lenvatinib Mesilate Capsules Typical Distributors

Table 25. by Type, Global Lenvatinib Mesilate Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Lenvatinib Mesilate Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Lenvatinib Mesilate Capsules Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Lenvatinib Mesilate Capsules Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Lenvatinib Mesilate Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Lenvatinib Mesilate Capsules Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Lenvatinib Mesilate Capsules Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2020-2031

Table 35. Eisai Company Information, Head Office, Market Area, and Industry Position

Table 36. Eisai Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 37. Eisai Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Eisai Company Profile and Main Business

Table 39. Eisai Recent Developments

Table 40. Beacon Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 41. Beacon Pharmaceuticals Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 42. Beacon Pharmaceuticals Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Beacon Pharmaceuticals Company Profile and Main Business

Table 44. Beacon Pharmaceuticals Recent Developments

Table 45. Everest Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Everest Pharmaceuticals Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 47. Everest Pharmaceuticals Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Everest Pharmaceuticals Company Profile and Main Business

Table 49. Everest Pharmaceuticals Recent Developments

Table 50. Shilpa Medicare Company Information, Head Office, Market Area, and Industry Position

Table 51. Shilpa Medicare Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 52. Shilpa Medicare Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Shilpa Medicare Company Profile and Main Business

Table 54. Shilpa Medicare Recent Developments

Table 55. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 56. Qilu Pharmaceutical Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 57. Qilu Pharmaceutical Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Qilu Pharmaceutical Company Profile and Main Business

Table 59. Qilu Pharmaceutical Recent Developments

Table 60. Chia Tai Tianqing Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 61. Chia Tai Tianqing Pharmaceutical Group Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 62. Chia Tai Tianqing Pharmaceutical Group Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Chia Tai Tianqing Pharmaceutical Group Company Profile and Main Business

Table 64. Chia Tai Tianqing Pharmaceutical Group Recent Developments

Table 65. Aosaikang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 66. Aosaikang Pharmaceutical Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 67. Aosaikang Pharmaceutical Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Aosaikang Pharmaceutical Company Profile and Main Business

Table 69. Aosaikang Pharmaceutical Recent Developments

Table 70. Qingfeng Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 71. Qingfeng Pharmaceutical Group Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 72. Qingfeng Pharmaceutical Group Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Qingfeng Pharmaceutical Group Company Profile and Main Business

Table 74. Qingfeng Pharmaceutical Group Recent Developments

Table 75. Jiangsu Simcere Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 76. Jiangsu Simcere Pharmaceutical Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 77. Jiangsu Simcere Pharmaceutical Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Jiangsu Simcere Pharmaceutical Company Profile and Main Business

Table 79. Jiangsu Simcere Pharmaceutical Recent Developments

Table 80. CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 81. CSPC Pharmaceutical Group Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 82. CSPC Pharmaceutical Group Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. CSPC Pharmaceutical Group Company Profile and Main Business

Table 84. CSPC Pharmaceutical Group Recent Developments

Table 85. Sichuan Kelun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 86. Sichuan Kelun Pharmaceutical Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 87. Sichuan Kelun Pharmaceutical Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Sichuan Kelun Pharmaceutical Company Profile and Main Business

Table 89. Sichuan Kelun Pharmaceutical Recent Developments

Table 90. Chengdu Brilliant Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 91. Chengdu Brilliant Pharmaceutical Lenvatinib Mesilate Capsules Models, Specifications, and Application

Table 92. Chengdu Brilliant Pharmaceutical Lenvatinib Mesilate Capsules Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Chengdu Brilliant Pharmaceutical Company Profile and Main Business

Table 94. Chengdu Brilliant Pharmaceutical Recent Developments

List of Figures

Figure 1. Lenvatinib Mesilate Capsules Picture

Figure 2. Global Lenvatinib Mesilate Capsules Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Lenvatinib Mesilate Capsules Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Lenvatinib Mesilate Capsules Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Lenvatinib Mesilate Capsules Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Lenvatinib Mesilate Capsules Sales Quantity (K Units) & (2020-2031)

Figure 7. China Lenvatinib Mesilate Capsules Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Lenvatinib Mesilate Capsules Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Lenvatinib Mesilate Capsules Market Share of Global, 2020-2031

Figure 10. Global Lenvatinib Mesilate Capsules Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Lenvatinib Mesilate Capsules Key Participants, Market Share, 2024

Figure 12. Global Lenvatinib Mesilate Capsules Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Lenvatinib Mesilate Capsules Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Lenvatinib Mesilate Capsules Production Market Share & Forecast by Region, 2020-2031

Figure 15. Lenvatinib Mesilate Capsules Industry Chain

Figure 16. Lenvatinib Mesilate Capsules Procurement Model

Figure 17. Lenvatinib Mesilate Capsules Sales Model

Figure 18. Lenvatinib Mesilate Capsules Sales Channels, Direct Sales, and Distribution

Figure 19. 4mg

Figure 20. 10mg

Figure 21. by Type, Global Lenvatinib Mesilate Capsules Consumption Value, 2020-2031, US$ Million

Figure 22. by Type, Global Lenvatinib Mesilate Capsules Consumption Value Market Share, 2020-2031

Figure 23. by Type, Global Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 24. by Type, Global Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2020-2031

Figure 25. by Type, Global Lenvatinib Mesilate Capsules Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 26. Hospital

Figure 27. Pharmacy

Figure 28. Other

Figure 29. by Application, Global Lenvatinib Mesilate Capsules Consumption Value, 2020-2031, US$ Million

Figure 30. by Application, Global Lenvatinib Mesilate Capsules Revenue Market Share, 2020-2031

Figure 31. by Application, Global Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 32. by Application, Global Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2020-2031

Figure 33. by Application, Global Lenvatinib Mesilate Capsules Price, 2020-2031, (US$/Unit)

Figure 34. By Region, Global Lenvatinib Mesilate Capsules Consumption Value Market Share, 2020-2031

Figure 35. By Region, Global Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2020-2031

Figure 36. North America Lenvatinib Mesilate Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 37. By Country, North America Lenvatinib Mesilate Capsules Consumption Value Market Share, 2024

Figure 38. Europe Lenvatinib Mesilate Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, Europe Lenvatinib Mesilate Capsules Consumption Value Market Share, 2024

Figure 40. Asia Pacific Lenvatinib Mesilate Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country/Region, Asia Pacific Lenvatinib Mesilate Capsules Consumption Value Market Share, 2024

Figure 42. South America Lenvatinib Mesilate Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, South America Lenvatinib Mesilate Capsules Consumption Value Market Share, 2024

Figure 44. Middle East & Africa Lenvatinib Mesilate Capsules Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. United States Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 46. by Type, United States Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 47. by Application, United States Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 48. Europe Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 49. by Type, Europe Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, Europe Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 51. China Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 52. by Type, China Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, China Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 54. Japan Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 55. by Type, Japan Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Japan Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 57. South Korea Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 58. by Type, South Korea Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, South Korea Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 60. Southeast Asia Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 61. by Type, Southeast Asia Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Southeast Asia Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 63. India Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 64. by Type, India Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, India Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 66. Middle East & Africa Lenvatinib Mesilate Capsules Sales Quantity, 2020-2031, (K Units)

Figure 67. by Type, Middle East & Africa Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Middle East & Africa Lenvatinib Mesilate Capsules Sales Quantity Market Share, 2024 VS 2031

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up Approaches

Figure 72. Top-down Approaches